Cours ME Therapeutics Holdings Inc.
Actions
METX
CA5527671054
Recherche biotechnologique et médicale
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
4,02 CAD | +0,25% | +1,77% | +235,00% |
1 jour | +0,25% | ||
1 semaine | +1,77% | ||
Mois en cours | +1,52% | ||
1 mois | +9,54% | ||
3 mois | +146,63% | ||
6 mois | -20,00% | ||
Année en cours | +235,00% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Salim Dhanji
CEO | Chief Executive Officer | 44 | 09/03/23 |
Quinn Martin
DFI | Director of Finance/CFO | 42 | 09/03/23 |
Jamil Kassam
SEC | Corporate Secretary | 44 | 09/03/23 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Karim Nanji
BRD | Director/Board Member | 57 | 07/06/23 |
Salim Dhanji
CEO | Chief Executive Officer | 44 | 09/03/23 |
Kenneth Harder
BRD | Director/Board Member | 57 | 09/03/23 |
Varia. 1 janv. | Capi. | |
---|---|---|
+235,00% | 69,78 M | |
+33,37% | 50,85 Md | |
+1,55% | 42,82 Md | |
+49,17% | 42,03 Md | |
-4,22% | 29,55 Md | |
+11,57% | 26,11 Md | |
-21,00% | 19,13 Md | |
+7,36% | 13,05 Md | |
+28,30% | 12,16 Md | |
+23,80% | 12,08 Md |